Clinical Trial Update: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares tretinoin, cytarabine, and daunorubicin with or without arsenic trioxide, followed by tretinoin with or without mercaptopur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• CYTARABINE (CYTARABINE)
• Daunorubicin hydrochloride (daunorubicin hydrochloride)
• METHOTREXATE (METHOTREXATE)
• Mercaptopurine (Mercaptopurine)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3) | Phase 3 | Status: COMPLETED